Electroacupuncture for Postoperative Urinary Retention After Cervical Cancer Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, blinded, single-center randomized study enrolling 208 participants with POUR after radical hysterectomy for cervical cancer. Participants are randomized 1:1 to receive either electroacupuncture or sham electroacupuncture in addition to conventional care, with 104 people per arm. The primary outcome is the proportion who can successfully have their urinary catheter removed; secondary outcomes include changes in post-void residual bladder volume, incidence of urinary tract infections, and quality of life measured by EORTC QLQ-C30. Eligibility includes adults 18–70 with POUR of less than 6 months and adequate performance status; several exclusion criteria screen for other urinary conditions, comorbidities, and contraindications to electrical stimulation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ① 18 to 70 years old;
* ② Anticipated survival of at least 6 months;
* ③ Met the diagnostic criteria for POUR of cervical cancer, and the duration of POUR is less than 6 months;
* ④ No serious urinary system disease in the past, and no urinary retention before operation;
* ⑤ Karnofsky functional status score (KPS) ≥ 70 points;
* ⑥ Stable vital signs, no serious mental illness, capable of daily living, able to cooperate in completing all treatments and examinations;
* ⑦ Voluntarily participate and sign a written informed consent form.

Exclusion Criteria:

* ① Obstructive urinary retention, such as urethral stricture or stones induced urinary system diseases;
* ② Merge other serious systemic diseases, and advanced cachexia patients;
* ③ Patients who are intolerant to electrical stimulation therapy, such as those with pacemakers installed;
* ④ With psychiatric disorder or severe cognitive impairment;
* ⑤ Severe skin damage, infection, and ulceration at the treatment site;
* ⑥ Those who are participating in other acupuncture or drug clinical trials.

Where it's running

• Zhejiang Cancer Hospital
  Hangzhou, Zhejiang, China Recruiting

Study contacts

• Study coordinator: Chao Lu
• Email: 1069103617@qq.com
• Phone: 15869128904

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transcutaneous electrical acupoint stimulation for postoperative urinary retention after radical hysterectomy for cervical cancer

  We will try transcutaneous electrical acupoint stimulation (TEAS) versus a sham TEAS to help people who cannot fully empty their bladder after radical hysterectomy for cervical cancer.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07235371

• Impact of Tamsulosin on Urinary Retention After Urogynecology Surgery

  This study tests if giving tamsulosin before pelvic surgery can help patients avoid needing a catheter after their operation.

  Recruiting Phase 3 TriHealth Inc. · Cincinnati, Ohio · NCT06843538

• Me capegfilgrastim to help prevent neutropenia in advanced breast cancer patients on chemotherapy

  This real-world registry tests whether mecapegfilgrastim used with chemotherapy helps prevent low white blood cells in adults with advanced breast cancer.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07899099

• Pucotenlimab and Anlotinib with Chemo Before Surgery for Early-Stage Triple-Negative Breast Cancer

  This study tests a combo of pucotenlimab, anlotinib, and nab-paclitaxel before surgery in adults with newly diagnosed, stage II-III triple-negative breast cancer that is PD-L1 known.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou · NCT07896668

• Anti-PD-1 with chemotherapy and intraperitoneal nab-paclitaxel for untreated advanced gastric cancer with ascites

  This study tests whether adding anti-PD-1 therapy to standard chemotherapy plus intraperitoneal nab-paclitaxel can help patients with untreated advanced gastric cancer and malignant ascites.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07855640

• Carbon ion lattice radiotherapy for large thoracic tumors

  This study tests a carbon ion lattice radiotherapy approach, after induction chemoimmunotherapy, in adults with unresectable locally advanced NSCLC or other thoracic solid tumors.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07744074

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.